These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20363412)

  • 61. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
    O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
    Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cytologic criteria for the formation of a risk group in Barrett esophagus].
    Kubasheva NS; Shibanova AI; Dzhumashev EZ
    Lab Delo; 1991; (2):34-6. PubMed ID: 1709983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Reflux esophagitis and Barrett's esophagus].
    Yuguero del Moral L; Ojeda Giménez C; Coma del Corral MJ; Velasco Oses A; Seco Gil JL; del Moral Garcia A; Calvo Fernández S
    Rev Esp Enferm Apar Dig; 1982 May; 61(5):388-97. PubMed ID: 7122953
    [No Abstract]   [Full Text] [Related]  

  • 66. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 67. Gastroesophageal reflux and cancer.
    Turcotte S; Duranceau A
    Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus.
    Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A
    Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of age and sex on endoscopic findings of gastrooesophageal reflux disease: an endoscopy database study.
    Menon S; Jayasena H; Nightingale P; Trudgill NJ
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):389-95. PubMed ID: 21448069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of lifestyle on Barrett's Esophagus: A precursor to esophageal adenocarcinoma.
    Navab F; Nathanson BH; Desilets DJ
    Cancer Epidemiol; 2015 Dec; 39(6):885-91. PubMed ID: 26519660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
    Nguyen T; Thrift AP; Yu X; Duan Z; El-Serag HB
    Am J Gastroenterol; 2017 Jul; 112(7):1049-1055. PubMed ID: 28244499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett's esophagus.
    Steevens J; Schouten LJ; Driessen AL; Huysentruyt CJ; Keulemans YC; Goldbohm RA; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):345-58. PubMed ID: 21173169
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Barrett's esophagus: so what!
    van Blankenstein M
    Dis Esophagus; 2002; 15(1):1-4. PubMed ID: 12060035
    [No Abstract]   [Full Text] [Related]  

  • 74. Adenocarcinoma in Barrett's esophagus.
    Barret M; Chaussade S; Coriat R
    N Engl J Med; 2011 Dec; 365(26):2539; author reply 2539-40. PubMed ID: 22204731
    [No Abstract]   [Full Text] [Related]  

  • 75. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
    Ortner M; Lochs H
    Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692
    [No Abstract]   [Full Text] [Related]  

  • 76. The problems with surveillance of Barrett's esophagus.
    Kahrilas PJ
    N Engl J Med; 2011 Oct; 365(15):1437-8. PubMed ID: 21995392
    [No Abstract]   [Full Text] [Related]  

  • 77. [Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study].
    Zöpf T; Rosenbaum A; Apel D; Jakobs R; Arnold JC; Riemann JF
    Med Klin (Munich); 2001 Apr; 96(4):212-6. PubMed ID: 11370603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is symptom control the correct end point for proton pump inhibitor treatment in Barrett's oesophagus?
    Sarela AI; Verbeke CS; Pring C; Guillou PJ
    Gut; 2004 Sep; 53(9):1387-8. PubMed ID: 15306606
    [No Abstract]   [Full Text] [Related]  

  • 79. Chemoprevention of Barrett's esophagus and oral leukoplakia.
    Garewal HS
    Adv Exp Med Biol; 1992; 320():129-36. PubMed ID: 1442277
    [No Abstract]   [Full Text] [Related]  

  • 80. [Modern aspects of photodynamic therapy of esophageal].
    Duvanskiĭ VA; Kniazev MV; Pravednikov PV
    Eksp Klin Gastroenterol; 2011; (10):111-6. PubMed ID: 22629709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.